|
Sign In to gain access to subscriptions and/or personal tools.
|
Vasculitis in systemic lupus erythematosus
D D'Cruz
Bone and Joint Research Unit, Royal London Hospital, London, UK
Vasculitis frequently complicates SLE, is associated with significant morbidity and mortality, and its pathophysiology is poorly understood. In seriously ill lupus patients with vasculitis, immunosuppression should almost always be considered.
Key Words: vasculitis systemic lupus erythematosus anti-endothelial antibodies
Lupus, Vol. 7, No. 4,
270-274 (1998)
DOI: 10.1191/096120398678920082

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Ebner, F. Picard, J. Richter, E. Darrelmann, M. Schneider, B.-E. Strauer, and M. Brehm
Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE
Rheumatology,
January 1, 2010;
49(1):
63 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Gomes, J. Carvalho, E. Borba, C. Borges, M. Vendramini, C Bueno, L. Costa, and E Bonfa
Digital vasculitis in systemic lupus erythematosus: a minor manifestation of disease activity?
Lupus,
October 1, 2009;
18(11):
990 - 993.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jain, J. Deveikis, S. Hickenbottom, and S. K. Mukherji
Varicella-Zoster Vasculitis Presenting with Intracranial Hemorrhage
AJNR Am. J. Neuroradiol.,
May 1, 2003;
24(5):
971 - 974.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|